0:00 0:00 1x

This is read by an automated voice. Please report any issues or inconsistencies here .

An inquiry into an infant botulism outbreak tied to ByHeart formula has expanded to include all the company’s products made since 2022, affecting at least 51 babies nationwide.

ByHeart had documented contamination problems, including a 2022 recall, an FDA warning letter and a plant closure linked to mold, leaks and insects.

Families of affected infants are suing ByHeart for negligence, seeking compensation for medical bills, emotional distress and losses they say were preventable.

Federal health officials on Wednesday expanded an outbreak of infant botulism tied to recalled ByHeart baby formula to include all illnesses reported since the company began production in March 2022.

Th

See Full Page